Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Introduction - Evidence-Based Medicine for Haematology
1. Jewish General Hospital
LIFE SCIENCES LIBRARY Library
Introduction:
Evidence-Based Medicine for
Haematology
Chantal Cassis, MD
Robin Featherstone, MLIS
Francesca Frati, MLIS
Summer 2012 Roland Grad, MDCM MSc FCFP
3. Workshop 1 - Objectives
By the end of the workshop, you will be able to:
1. Describe the five stages of the EBM process
2. Differentiate background from foreground
questions
3. Develop a well-formed PICO question
4. Categorize PICO questions and identify the best
studies to answer each question type
5. Select an appropriate source to search for evidence
to best answer your PICO questions
4. EBM for Haematology
Pilot program designed for
specialist residents
Focused on real-life
clinical questions
Aims to integrate EBM
into your everyday practice
7. Workshops
July 25 - Introduction to EBM for Haematology
Aug 8 - Hands-on Searching Workshops
Aug 22 - Critical Appraisal
Sept 5 - Resident Presentations
Sept 19 - Review
8. EBM Process
Formulating
Workshop Evaluating the clinical
the Process Workshop
5 question
1
Your patient for whom
you are uncertain about
therapy, diagnosis, or Searching
Incorporating prognosis the Evidence
evidence into
Workshop
decision-making
2
Workshop
Workshop 3
4
Appraising
the Evidence
9. Can a 70 year old
pancytopenic patient
with suspected
meningitis receive
platelets before
undergoing a lumbar
puncture?
What is pancytopenia?
What is the diagnostic
test for meningitis?
[1.]
Guyatt G, Rennie D, Cook D. Users' Guides to the Medical Literature : A Manual for Evidence-Based Clinical Practice (2nd
Edition). New York, NY, USA: McGraw-Hill Professional Publishing; 2008.
11. Patient Scenario
You are following a 35 year-old pregnant female for low
platelets thought to be due to immune thrombocytopenia as
she had thrombocytopenia prior to her pregnancy. During the
pregnancy, her platelets fluctuated quite a bit, ranging from
her pre-pregnant baseline of 120 to as low as 60. When she
presented to hospital in labour, her platelets count was 75
preventing her from getting an epidural, but ensuring a safe
delivery.
She undergoes a spontaneous vaginal delivery without
complications. She and the baby are medically ready to leave
the hospital 48 hours later. Her platelet count has risen to
110. She asked if she should be concerned for her newborn,
knowing that her antibodies, the same that are causing her
immune thrombocytopenia, are passed along to baby. Should
a blood test be done to check the baby’s platelet count. If so,
when?
12. Formulating a Clinical Question
Patient, population, or problem
Intervention, prognostic factor, or exposure
Comparison or intervention
Outcomes to measure or be achieved
13. What’s the PICO?
You are following a 35 year-old pregnant female for low
platelets thought to be due to immune thrombocytopenia as
she had thrombocytopenia prior to her pregnancy. During the
pregnancy, her platelets fluctuated quite a bit, ranging from
her pre-pregnant baseline of 120 to as low as 60. When she
presented to hospital in labour, her platelets count was 75
preventing her from getting an epidural, but ensuring a safe
delivery.
She undergoes a spontaneous vaginal delivery without
complications. She and the baby are medically ready to leave
the hospital 48 hours later. Her platelet count has risen to
110. She asked if she should be concerned for her newborn,
knowing that her antibodies, the same that are causing her
immune thrombocytopenia, are passed along to baby. Should
a blood test be done to check the baby’s platelet count. If so,
when?
14. PICO
P: Newborns born to mothers with immune
thrombocytopenia
I: Blood test to check platelet count
C: No blood test
O: Diagnosis of immune thrombocytopenia
15. Clinical Question
In newborn patients with suspected immune
thrombocytopenia, is a blood test to
determine platelet count recommended to
diagnose immune thrombocytopenia?
16. What is the “evidence”?
Systematic Reviews
Case-control studies
Randomized control trials
Cohort studies Case reports
Editorials
Animal research
All types of articles found in PubMed
17. Question Best Evidence
Cost •Cost-effectiveness study
Diagnosis •Diagnostic validation studies
•Prospective studies / blind comparison to a
gold standard
Etiology/Harm •Cohort study
•Case control study
Prognosis •Cohort study
•Case control study
Quality of life •Qualitative studies
Therapy •Systematic review of Randomized Controlled
Trials (RCTs)
•Single RCT
1 Heneghan, Carl, and Douglas Badenoch. Evidence-Based Medicine Toolkit. 2nd ed. Malden, Mass.: BMJ Books/Blackwell Pub., 2006.
2 Glover, Jan, and Lei Wang. Find it Fast: The Clinical Question : www.med.yale.edu/library/education/guides/screencasts/finditfast/finditfast_2/
18. Levels of Evidence
for Therapy Question
Level of Evidence Type of Study
1a Systematic reviews of randomized controlled trials
(RCTs)
1b Individual RCTs with narrow confidence interval
2a Systematic reviews of cohort studies
2b Individual cohort studies and low-quality RCTs
3a Systematic reviews of case-control studies
3b Case-control studies
4 Case series and poor quality cohort and case-control
studies
5 Expert opinion
Levels of evidence (2001). Centre for Evidence Based Medicine. Retrieved 26 Aug 2008 from
http://www.cebm.net/index.aspx?o=1025 18
19. Information Sources
for Diagnosis Question
Synopsis
of
synthesis
Summaries
Filtered
1b 1a 1b 1a
2b 2a 2b 2a
Unfiltered
3b 3b
4 5 4 5
20. Criteria for Selecting an Information
Source
1. Soundness of evidence-based approach
2. Comprehensiveness and specificity
3. Ease of use
4. Availability
See also:
http://www.jgh.ca/en/hslinteractivepyramid
21. Information Sources
some examples
} includes:
• Cochrane
Database of
Systematic
Reviews
• DARE (Database
Filtered
of Abstracts of
Reviews of Effects)
27. What’s the PICO?
A 25 year-old female has been recently diagnosed with classical
Hodgkin’s lymphoma (nodular sclerosing subtype). Staging reveals that
she is a stage IIA (early favorable HL) with a 4.5 cm nodal mass in her
neck and mediastinal nodes. You recommend combined modality therapy
(chemotherapy /- radiation therapy). The patient has done some reading
about therapy and is worried about the long term effects of radiation
especially the risk of breast cancer.
She asked you if combined modality therapy is truly superior to
chemotherapy alone?
What if she was a stage IIB (early unfavorable)?
She agrees to begin ABVD chemotherapy and asked if she will be getting
G-CSF (neupogen) injection to ensure that her white blood cells recover
prior to the subsequent chemotherapy cycle. You inquire with your
colleagues and realize that some give all their patients neupogen while
others never do. Is there a benefit to giving neupogen while getting
ABVD?
28. Possible PICO 1
P: 25 year old female with stage IIA
Hodgkin’s Lymphoma
I: Combined modality therapy
C: Chemotherapy alone
O: Risk of breast cancer
29. Possible PICO 2
P: 25 year old female with stage IIB
Hodgkin’s Lymphoma
I: Combined modality therapy
C: Chemotherapy alone
O: Risk of breast cancer
30. Possible PICO 3
P: Patient undergoing ABVD chemotherapy
I: G-CSF (neupogen) injection
C: No neupogen
O: Recovery of white blood cells prior to
chemotheraphy
31. Possible PICO 4
P: 25 year old female with stage IIA
Hodgkin’s Lymphoma
I: Combined modality therapy
C: Chemotherapy alone
O: Most effective treatment
32. Summary Quiz
1. UpToDate is a _______ resource. And
EMBASE is a ________ resource.
2. The 5 stages in the EBM process are _______.
3. The best evidence to answer a diagnosis
question is _______.
4. To find systematic reviews of RCTs use
_______.
5. PICO stands for ________.
33. Homework
For next workshop (9 am to noon, Aug 8th, JGH A-805)
record two PICO formulated clinical questions encountered
during practice
Send one PICO to instructor –
robin.featherstone@mcgill.ca – by 5 pm on Aug 1.
If you don’t have a PICO, let us know by Aug 1
Bring these PICO questions to the next workshop
Slides available:
Notes de l'éditeur
Ask the residents what they know about Evidence Based Medicine and why they should practice it. Key points:Mandated by the Royal College of Physicians and Surgeons of CanadaMandated by the Accreditation Council for Graduate Medical EducationAllows you to identify flawed research (residency program directors really like this)Allows you to apply research findings to patient care (residency program directors really like this too)Helps you comprehend research methodology (probably a good idea if you’re going to be conducting research… not to mention using research to inform clinical decision-making!)
Process can also be described as: Ask, Acquire, Appraise, Apply and Assess
To format foreground questions, use PICO. Note: not all PICO elements are mandatory, but (in my experience) the P and the I are pretty much always included. Why is it important? (1) helps to keep the question clear and avoid side-tracking (2)helps avoid changing to question to suit the evidence (3) helps avoid looking for what you think you will find (4)helps to identify when more than one search is needed to answer the full question in cases where there are multiple PICOs
Note: In the case of babies born to mother's with immune thrombocytopenia, they merely passively acquire their mom's antibodies via the placenta and so they do not have immune thrombocytopeniaAnother possible PICO question includes the timing of the test.
From here, you have many choices to conduct your search. You want the best, most reliable evidence possible.
From here, you have many choices to conduct your search. You want the best, most reliable evidence possible.
Mention how EBM works really well for therapy questions. That the levels of evidence doesn’t necessarily apply for all kinds of question types. Take your question and the search the literatureLooking for the best evidence possible for your question. For questions of therapy = Systematic ReviewsBut there aren’t always systematic reviews for your questionSo you have to move down the list to the best type of evidence available for your questionOne reason it is important to understand the different types of study designs that you are learning about in this course. –if you understand the study design, you will understand the studies and the best evidence. --understand why a cohort study is better than a case-control studyYou will also hear about something called “Levels of Evidence” and this is just short hand for these types of studies. (click to reveal levels)So if you see somewhere that a question has level 1a evidence, you know that there is a systematic review of RCTs to support the answer to that question. It is just a shorthand instead of having to say sys rev of RCT all of the time. the best evidence available may not be the highest level of evidence attainable for a specific clinical question. Findings from such research would receive a lower grade of recommendation that for a clinical question answered by a higher level of evidence.study
Click to start animation1a – Systematic reviews of randomized controlled trials1b – Individual RCTs with narrow confidence interval2a – Systematic reviews of cohort studies2b - Individual cohort studies and low-quality RCTs3a – Systematic reviews of case-control studies3b – Case-Control Studies4 – Case series and poor quality cohort and case-control studies5 – Expert opinion
Questions to ask:Bias? Conflict of interest? Evidence grading or ranking applied? Links? Discipline coverage? Consistent and quick to search? Cost? Available in my location?
Some controversy over where UpToDate belongs. Could be used to answer background or foreground questions. Could be considered “evidence-based” tool, or expert opinion. For the purposes of these courses, I would recommend UpToDate as being a higher level of evidence than expert opinion, but it should not be considered on the same level as a Cochrane Systematic Review. And UpToDate should definitely be considered a filtered information source. It will take you far less time to search than individual studies.